Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**p-chlorophenylalanine** is a synthetic amino acid derivative that acts as a selective and irreversible inhibitor of **tryptophan hydroxylase**, the rate-limiting enzyme in the biosynthesis of serotonin. By inhibiting this enzyme, p-chlorophenylalanine depletes serotonin in the brain. It is primarily used in research to study serotonin pathways and the physiological and behavioral consequences of serotonin depletion. p-chlorophenylalanine is not approved for human clinical use and is distributed for laboratory or research purposes only[2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on p-chlorophenylalanine.